Tag : Medical

CCT Impact

Parkinson’s Foundation Releases Results of First-Ever Medical Cannabis and Parkinson’s Disease Survey

CCT IMPACT Agent
The Parkinson’s Foundation today announced the results of the medical cannabis and Parkinson’s disease (PD) survey. The survey, titled Weeding Through the Haze: A Survey on Cannabis Use Among People Living with Parkinson’s Disease in the U.S., was distributed to 7,607 people with PD in January 2020, with 1,064 complete responses analyzed. Parkinson’s Foundation Medical......
CCT Impact

Medical Cannabis’ Burgeoning Reputation is a Boon for the Market’s Expansion

CCT IMPACT Agent
The cannabis industry has drastically changed over the course of the last five years. Thanks to shifting consumer sentiments, legislative victories across several major states and the availability of new products for a wide demographic, the cannabis industry has become a major market attracting investors from all over the world.......
CCT Impact

NuggMD Brings Its Industry-Leading Medical Marijuana Telemedicine Service to Virginia

CCT IMPACT Agent
NuggMD, the nation’s leading medical cannabis telemedicine platform, is launching their online services to patients in Virginia for just $149 per visit. NuggMD currently offers services in Nevada, New York, Missouri, Ohio, Pennsylvania, California, Oklahoma and New Jersey. They’ve connected over 650,000 patients with their fully-licensed medical marijuana doctors since 2016. Their expansion into Virginia brings a vital telemedicine option for current and prospective medical......
CCT Impact

LYPHE Group imports Northern Green Canada into the U.K. market as supply to the medical cannabis brand, NOIDECS

CCT IMPACT Agent
LYPHE Group, U.K.’s leading medical cannabis provider, with more than 60% of the British patient market, and Canadian independent EU GMP manufacturer, Northern Green have entered into a supply partnership that will see a range of indoor grown flowers enter the market under the brand name of NOIDECS. The flowers......
CCT Impact

Unprecedented international achievement for Panaxia: selected as one of the four main winners in the French government tender for regulation of the medical cannabis industry

CCT IMPACT Agent
Dr. Dadi Segal, CEO of Panaxia Global, said, “Our success in this prestigious French government tender along with our partner, Neuraxpharm, is a huge achievement for Panaxia, and we are proud to be part of the elite group of global medical cannabis leaders selected for the program. The fact that four......
CCT Impact

Surterra Texas™ Launches First Medical Cannabis Gummies for the Texas Compassionate Use Program

CCT IMPACT Agent
 Surterra Texas, a division of the privately-held, multi-state, cannabis company Parallel and a leading medical cannabis company, today announced the availability of the first cannabis-infused gummies for patients in Texas. This introduction of gummies further expands Surterra Texas’ market-leading product portfolio, providing Texans with the state’s largest assortment of cannabis-based medicines and......
CCT Impact

Medical Cannabis Market Size is USD 30520 Million by 2026 at CAGR of 13.0% | Valuates Reports

CCT IMPACT Agent
Medical Cannabis Market is Segmented by Type (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)), by Application (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)), by Regions & Key players Regional Growth: Global Opportunity Analysis and Industry Forecast, 2021–2026. This report is published on Valuates Reports in the Pharmaceuticals Category. The global Medical Cannabis Market size......
CCT Impact

Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor’s AKVANO® technology

CCT IMPACT Agent
Lipidor AB (Nasdaq First North:LIPI) today announced that the Company has signed an exclusive licensing agreement with Cannassure Therapeutics Ltd. (TASE:CSURE), an Israeli company specializing in the development and manufacture of innovative medicinal cannabis products. Under the agreement, Cannassure has the exclusive right to use Lipidor’s proprietary drug delivery technology......
CCT Impact

Bazelet launches first-of-the kind, proprietary, terpene-enriched medical cannabis oils specially designed for medical needs such as women health, pain treatment, improved sleep and special needs of the elderly population

CCT IMPACT Agent
Bazelet, the largest medical company in Israel, has made a breakthrough in medical cannabis products, in launching multiple lines of terpene-enriched cannabis oils, each one of which being specifically designed for one of various indications, symptoms and personal needs. Bazelet terpene-enriched products are optimized for woman health, for elderly population needs,......
CCT Impact

NuggMD Expands Its Service to New Jersey; Surpasses 650,000 Medical Marijuana Cards Issued

CCT IMPACT Agent
NuggMD, the nation’s leading medical cannabis telemedicine service announced today that it is expanding its service to New Jersey patients, which will be the eighth state the company serves. The news comes as the company reaches an impressive milestone — over 650,000 medical cannabis cards have been issued to patients by licensed......